Late antibody-mediated rejection after heart transplantation following the development of de Novo Donor-specific human leukocyte antigen antibody

Transplantation

Volumn 93, Issue 6, 2012, Pages 650-656

  Hodges, Aidan M ^a,b   Lyster, Haifa ^c   McDermott, Anne ^c   Rice, Alexandra J ^c   Smith, John D ^c   Rose, Marlene L ^c   Banner, Nicholas R ^c  

^a HAREFIELD HOSPITAL   (United Kingdom)

^b NATIONAL HEART AND LUNG INSTITUTE   (United Kingdom)

^c NONE

Author keywords

[No Author keywords available]

Indexed keywords

AZATHIOPRINE; BORTEZOMIB; HLA ANTIBODY; IMMUNOGLOBULIN; METHYLPREDNISOLONE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; RAPAMYCIN; RITUXIMAB; TACROLIMUS;

ADULT; AGED; ANTIBODY PRODUCTION; ANTIBODY SPECIFICITY; APHERESIS; ARTICLE; CARDIAC ALLOGRAFT VASCULOPATHY; CARDIAC GRAFT REJECTION; CLINICAL ARTICLE; CLINICAL FEATURE; COHORT ANALYSIS; CONTROLLED STUDY; FEMALE; HEART FAILURE; HEART MUSCLE BIOPSY; HEART TRANSPLANTATION; HUMAN; HUMAN TISSUE; IMMUNEPHERESIS; IMMUNOADSORPTION; INCIDENCE; IRRADIATION; MALE; OBSERVATIONAL STUDY; PLASMAPHERESIS; POSTOPERATIVE PERIOD; PREVALENCE; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SURVIVAL RATE; TREATMENT OUTCOME;

ADULT; AGED; ANTIBODIES; ANTIBODIES, MONOCLONAL, MURINE-DERIVED; BORONIC ACIDS; COHORT STUDIES; FEMALE; GRAFT REJECTION; HEART TRANSPLANTATION; HLA ANTIGENS; HUMANS; IMMUNOGLOBULINS, INTRAVENOUS; INCIDENCE; KAPLAN-MEIER ESTIMATE; LYMPH NODES; MALE; MIDDLE AGED; PYRAZINES; RETROSPECTIVE STUDIES; SURVIVAL RATE; TIME FACTORS; TISSUE DONORS; TREATMENT OUTCOME;

EID: 84862776874     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/TP.0b013e318244f7b8     Document Type: Article

References (0)